IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants.The IlluminOss System utilizes a light-curable polymer, contained within an expandable balloon catheter to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in the EU under a CE Mark and is FDA approved in the U.S.A for treatment of traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, and ulna in skeletally mature patients. The IlluminOss System can also be used in conjunction with an FDA-cleared fracture fixation system to provide supplemental fixation in the humerus, radius, and ulna.Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Tekla Capital, Life Sciences Partners, SR One, Pappas Ventures, and Slater Technology.